KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer.
Galan-Cobo A, Vokes NI, Qian Y, Molkentine D, Ramkumar K, Paula AG, Pisegna M, McGrail DJ, Poteete A, Cho S, Do MT, Karimi A, Kong Y, Solanki A, Karmokar A, Floc'h N, Hughes A, Sargeant R, Young L, Shen L, Kar G, Keshvani C, Arrechedera C, Hernandez S, Schlacher K, Wang J, Iyer S, Conway J, Keddar MR, Milo M, de Toma I, Critchlow SE, Barrett JC, Cosaert J, Lau A, Valge-Archer V, Byers LA, Barry ST, Heymach JV.
Galan-Cobo A, et al. Among authors: qian y.
Cancer Cell. 2025 Jul 5:S1535-6108(25)00261-2. doi: 10.1016/j.ccell.2025.06.011. Online ahead of print.
Cancer Cell. 2025.
PMID: 40645185